Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Cannabics Pharmaceuticals Inc. (OTC: CNBX).

Full DD Report for CNBX

You must become a subscriber to view this report.


Recent News from (OTC: CNBX)

Cannabics Pharmaceuticals Granted Patent in Israel for Its Core Technology for Personalized Cannabinoid Based Medicine
TEL AVIV, Israel and BETHESDA, Maryland , Sept. 5, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, has been granted its patent for its core technology by the Israeli Patent Office....
Source: PR Newswire
Date: September, 05 2018 09:30
Cannabics Pharmaceuticals Inc. Appoints Dr. Estery Giloz-Ran to Its Advisory Board
TEL AVIV, Israel , August 28, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, Board of Directors is proud to announce its addition of Dr Giloz-Ran, former manager of Grants Capital...
Source: PR Newswire
Date: August, 28 2018 13:02
Cannabics Pharmaceuticals Announces That Seedo is to End Pre-Sales and Commence Delivery of Its Automated Growing Devices
Aug. 22, 2018 , TEL AVIV , Israel and BETHESDA, Maryland /PRNewswire/ --  Cannabics Pharmaceuticals Inc.  (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that Eroll Grow Tech Ltd (" Seedo "), develop...
Source: PR Newswire
Date: August, 22 2018 10:22
Cannabics Pharmaceuticals Partners with Eroll Grow Tech to Create First Auto-Grow Device for Medical Cannabis
TEL AVIV, Israel and BETHESDA, Maryland , Aug. 14, 2018 /PRNewswire/ --  Cannabics Pharmaceuticals Inc.  (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced a partnership agreement with Eroll Grow Tech ltd (" See...
Source: PR Newswire
Date: August, 14 2018 09:00
5 of Today's Biggest Marijuana Stock Losers - Monday, August 13th
Out of over 200+ marijuana stocks, here are just 5 of the biggest marijuana stock losers in trading on Monday, August 13th including Affinor Growers Inc. (CSE:AFI) (OTC:RSSFF) and more... Affinor Growers Inc. (OTC:RSSFF) (CSE:AFI) Shares of Affinor Growers Inc. dropped 8.54% today on hi...
Source: Daily Marijuana Observer
Date: August, 13 2018 18:48
Cannabics Pharmaceuticals Announces Attendance at the Benzinga Cannabis Capital Conference
TEL AVIV, Israel and BETHESDA, Maryland , Aug. 10, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that its CEO, Mr. Eyal Barad , will be attending the Benzinga Cann...
Source: PR Newswire
Date: August, 10 2018 09:30
Join Cannabics Pharmaceuticals at the MJBizCon Held at Metro Toronto Convention Center, Toronto, August 14-16, 2018
TEL AVIV , Israel and BETHESDA, Maryland, August 9, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc.  (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that its CEO, Mr. Eyal Barad , will be attend...
Source: PR Newswire
Date: August, 09 2018 09:30
Cannabics Pharmaceuticals' CEO Issues Letter to Shareholders
TEL AVIV, Israel and BETHESDA, Maryland , Aug. 2, 2018 /PRNewswire/ -- Dear Fellow Shareholders, I am pleased to announce that we have entered the second half of 2018 with strong momentum. Now that we have officially moved into our new state-of-the-art Cancer Screening Laboratory lo...
Source: PR Newswire
Date: August, 02 2018 13:45
Join Cannabics Pharmaceuticals at the National Cannabis Industry Association's Cannabis Business Summit and Expo Held at San Jose Convention Center, California USA, July 25-27, 2018
TEL AVIV , Israel and BETHESDA, Maryland, July 11, 2018 /PRNewswire/ --  Cannabics Pharmaceuticals Inc.  (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that senior members of its team will be at...
Source: PR Newswire
Date: July, 11 2018 11:22
5 of Today's Biggest Marijuana Stock Gainers - Thursday, July 5th
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Thursday, July 5th including CV Sciences, Inc. (OTC:CVSI) and more... Cannabics Pharmaceuticals Inc. (OTC:CNBX) Shares of Cannabics Pharmaceuticals Inc. rose 5.00% on higher than average tr...
Source: Daily Marijuana Observer
Date: July, 05 2018 17:10

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-11-160.400.460.460.40196,180
2018-11-150.410.400.440.40262,665
2018-11-140.470.440.4850.425229,127
2018-11-130.51250.480.530.455296,796
2018-11-120.530.500.560.50122,201

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-1696,954196,18049.4209Short
2018-11-1547,793256,66518.6208Cover
2018-11-1449,243229,12721.4916Cover
2018-11-13135,914296,79445.7941Short
2018-11-1231,649122,20125.8991Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CNBX.


About Cannabics Pharmaceuticals Inc. (OTC: CNBX)

Logo for Cannabics Pharmaceuticals Inc. (OTC: CNBX)

Cannabics Pharmaceuticals Inc. CNBX , is dedicated to the development of personalized diagnostic tools to provide supportive data for practitioners and patients regarding cannabinoid based cancer therapy. The Company s R amp D is based in Israel, where it is fully licensed by the Ministry of Health and involves both scientific and current medical clinical studies which are registered with the US NIH. Cannabics is now creating tailored therapies for cancer patients, utilizing advanced Liquid Biopsy and HTS technology along with personalized bioinformatics tools. Cannabics research is devoted to the discovery of cannabinoid compounds targeted to specific cancers based on the confluence of cutting edge technologies and personalized bioinformatic markers.

 

 

 

Current Management

  • Eyal Barad / CEO
    • Eyal Barad , is a cofounder of Cannabics Inc., founded in , and is a core member of Cannabics Inc. s management team and brings years of executive managerial experience in successful technology and startup ventures. Mr. Barad received his BA in Economics amp International Relations from the Hebrew University in Jerusalem in , and an MBA with Honors from Haifa University in
  • Uri BenOr / CFO
    • Mr. BenOr has over years of broad experience in corporate finance, accounting, M amp A transactions and IPOs. He specializes in life science public companies listed for trade at the TASE and serves as the CFO of many of them. Mr. BenOr has a BA degree in Business from the College of Administration, a MBA degree from the Bar Ilan University and he is a Certified Public Accountant.
  • Eyal Ballan / CTO
  • Eyal Ballan /

Current Share Structure

  • Market Cap: $162,655,657 - 03/09/2018
  • Authorized: 900,000,000 - 02/28/2018
  • Issue and Outstanding: 120,485,672 - 02/28/2018
  • Float: 21,943,046 - 06/01/2017

 


Recent Filings from (OTC: CNBX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 14 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: January, 30 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: January, 16 2018
OTCQB Certification - OTCQB Certification
Filing Type: OTCQB Certification - OTCQB CertificationFiling Source: OTC Markets
Filing Date: January, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 19 2017
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: December, 08 2017
Notification that form 10-K will be submitted late
Filing Type: NT 10-KFiling Source: edgar
Filing Date: November, 29 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: November, 13 2017

 

 


Daily Technical Chart for (OTC: CNBX)

Daily Technical Chart for (OTC: CNBX)


Stay tuned for daily updates and more on (OTC: CNBX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: CNBX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CNBX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of CNBX and does not buy, sell, or trade any shares of CNBX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/